Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial
Bayer
Maha Hussain; Bertrand Tombal; Fred Saad; Karim Fizazi; Cora N Sternberg; E David Crawford; Neal Shore; Evgeny Kopyltsov; Arash Rezazadeh Kalebasty; Martin Bögemann; Dingwei Ye; Felipe Cruz; Hiroyoshi Suzuki; Shivani Kapur; Shankar Srinivasan; Frank Verholen; Iris Kuss; Heikki Joensuu; Matthew R Smith